BioSpace News Archive

Galectin Therapeutics, Inc. today reported financial results and provided a business update for the quarter ended March 31, 2024.

Toronto, Ontario--(Newsfile Corp. - May 15, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo”) a biotech company developing the industry’s leading telomere technology platform with diagnostic and prognostic applications in oncology is pleased to announce that...

Vertex Pharmaceuticals Incorporated announced that Jennifer Schneider, M.D., M.S., has been elected to its Board of Directors as an independent director.

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid toxicities that include acute cannabinoid intoxication (ACI) and unintentional cannabis poisoning (the “Company” or “Anebulo”), today announced financial results for the three months ended March 31, 2024, and recent updates.

Allucent, a global mid-sized clinical research organization, announced that it received a project award valued at $25.5 million through the Rapid Response Partnership Vehicle Consortium to conduct its Decentralized Home Focus COVID-19 Trial.

Global Cell Free Protein Synthesis Market is valued at US$ 265.9 Mn in 2023, and it is expected to reach US$ 457.1 Mn by 2031, with a CAGR of 7.2% during the forecast period of 2024-2031.

60 Degrees Pharmaceuticals, Inc., a pharmaceutical company focused on developing new medicines for infectious diseases, reported their financial results for the first fiscal quarter of the 2024 year, ended March 31, 2024.

AB Science SA reports its revenues for the year 2023 and provides an update on its activities.

Transformative Biotech, LLC, a molecular diagnostics technology company, announced the appointment of Dr. Barbara Handelin as Co-CEO and to its Board of Directors.

Recent advancements signify a new era in liver disease diagnosis and treatment.